MorphoSys (NASDAQ:MOR) Price Target Cut to €40.00 : v

MorphoSys (NASDAQ:MOR – Get Rating) had its target price lowered by analysts at Morgan Stanley from €50.00 ($54.95) to €40.00 ($43.96) in a research note issued to investors on Monday, The Fly reports. The brokerage currently has an “equal weight” rating on the stock. A number of other research analysts have also commented on the […]

Related Keywords

United States , , Morgan Stanley , Berenberg Bank , Zacks Investment Research , Deutsche Bank Aktiengesellschaft , Blackrock Inc , Alphacentric Advisors , Morphosys Company Profile Get Rating , Millennium Management , Citigroup , Get Rating , Bank Aktiengesellschaft , Investment Research , Bay Capital Management , Sys Company Profile , Morphosys , Nasdaq Mor , Humor , Medical , Lower Price Target ,